Connecting you to content on EBSCOhost

Works matching IS 17762596 AND DT 2018 AND VI 13 AND IP 3

Results: 12

1

Prognostic Impact of the Components of Progressive Disease on Survival After First-Line Tyrosine Kinase Inhibitor Therapy for Metastatic Renal Cell Carcinoma.

Published in:

2018

By:

Ikeda, Takashi;
Ishihara, Hiroki;
Takagi, Toshio;
Kondo, Tsunenori;
Yoshida, Kazuhiko;
Iizuka, Junpei;
Tanabe, Kazunari

Publication type:

journal article

2

Atezolizumab: A Review in Previously Treated Advanced Non-Small Cell Lung Cancer.

Published in:

2018

By:

Blair, Hannah A.

Publication type:

journal article

3

Medical Treatment Options for Patients with Epidermal Growth Factor Receptor Mutation-Positive Non-Small Cell Lung Cancer Suffering from Brain Metastases and/or Leptomeningeal Disease.

Published in:

2018

By:

Hochmair, Maximilian

Publication type:

journal article

4

Avelumab: A Review in Metastatic Merkel Cell Carcinoma.

Published in:

2018

By:

Shirley, Matt

Publication type:

journal article

5

Discovery of a Potent and Mutant-Selective EGFR Inhibitor that Overcomes T790M-Mediated Resistance in Lung Cancer.

Published in:

2018

By:

Kim, Dong Ha;
Choi, Yun Jung;
Kim, Seon Ye;
Lee, Jung-Eun;
Sung, Ki Jung;
Sung, Young Hoon;
Kim, Woo Sung;
Kim, Sung-Eun;
Ryu, Hyung Chul;
Kim, Jae Sun;
Guangying, Lu;
Choi, Chang-Min;
Rho, Jin Kyung;
Lee, Jae Cheol

Publication type:

journal article

6

The Role of Mesothelin as a Diagnostic and Therapeutic Target in Pancreatic Ductal Adenocarcinoma: A Comprehensive Review.

Published in:

2018

By:

Nichetti, Federico;
Marra, Antonio;
Corti, Francesca;
Guidi, Alessandro;
Raimondi, Alessandra;
Prinzi, Natalie;
de Braud, Filippo;
Pusceddu, Sara

Publication type:

journal article

7

The Impact of Dose and Simultaneous Use of Acid-Reducing Agents on the Effectiveness of Vemurafenib in Metastatic BRAF V600 Mutated Melanoma: a Retrospective Cohort Study.

Published in:

2018

By:

Knapen, Lotte M.;
Koornstra, Rutger H. T.;
Driessen, Johanna H. M.;
van Vlijmen, Bas;
Croes, Sander;
Schalkwijk, Stein;
Colbers, Angela;
Gerritsen, Winald R.;
Burger, David M.;
de Vries, Frank;
van Erp, Nielka P.

Publication type:

journal article

8

Association of Expression Levels or Activation Status of STAT3 with Treatment Outcomes of Sunitinib in Patients with Renal Cell Carcinoma.

Published in:

2018

By:

Yamamoto, Kazuhiro;
Hara, Takuto;
Nakagawa, Tsutomu;
Hirai, Midori;
Miyake, Hideaki;
Fujisawa, Masato;
Yano, Ikuko

Publication type:

journal article

9

Atezolizumab in Metastatic Urothelial Carcinoma Outside Clinical Trials: Focus on Efficacy, Safety, and Response to Subsequent Therapies.

Published in:

2018

By:

Barata, Pedro C.;
Gopalakrishnan, Dhrmesh;
Koshkin, Vadim S.;
Mendiratta, Prateek;
Karafa, Matt;
Allman, Kimberly;
Martin, Allison;
Beach, Jennifer;
Profusek, Pam;
Tyler, Allison;
Wood, Laura;
Ornstein, Moshe;
Gilligan, Timothy;
Rini, Brian I.;
Garcia, Jorge A.;
Grivas, Petros

Publication type:

journal article

10

Targeting BCL-2 in Hematologic Malignancies.

Published in:

2018

By:

Khan, Nadia;
Kahl, Brad

Publication type:

journal article

11

Antibody-Drug Conjugates for the Treatment of Hematological Malignancies: A Comprehensive Review.

Published in:

2018

By:

Rossi, Cédric;
Chrétien, Marie-Lorraine;
Casasnovas, René-Olivier

Publication type:

journal article

12

Prognostic and Predictive Factors for Renal Cell Carcinoma.

Published in:

2018

By:

Suárez, Cristina;
Campayo, Marc;
Bastús, Romà;
Castillo, Sergi;
Etxanitz, Olatz;
Guix, Marta;
Sala, Núria;
Gallardo, Enrique

Publication type:

journal article